Stocks gapping ≥20% at open — earnings flagged, AI catalyst research included
| Date | Ticker | Company | Sector | MCap | Prev Close | Open | Gap% | Earnings | Type | Conf |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20 Wed | IMVT | Immunovant, Inc. | Healthcare | 4.0B | $26.29 | $33.77 | +28.5% | BMO | clinical | 9 |
| IMVT-1402 demonstrated strong Phase 2 efficacy in difficult-to-treat rheumatoid arthritis (D2T RA): 72.7% ACR20 response rate, 54.5% ACR50, and 35.8% ACR70 at Week 16 in 165 evaluable patients with high baseline disease activity (mean 24.2 tender joints, 16.7 swollen joints, DAS28-CRP 6.1). In the subset failing JAK inhibitors and anti-TNF (N=107), response rates were 72.0% ACR20, 53.3% ACR50, 37.4% ACR70. Drug was well-tolerated with no new safety signals. Company has $902.1 million cash provid | ||||||||||
| May 19 Tue | AGYS | Agilysys, Inc. | Technology | 2.0B | $70.20 | $86.40 | +23.1% | AMC | guidance | 9 |
| FY2027 revenue guidance of $365M-$370M (vs. FY2026 record $319.3M, +14-16% growth) with subscription revenue growth of at least 30% for third consecutive year. Adjusted EBITDA margin expanding to 24% of revenue from 21.2% in FY2026. FY2026 beat on EPS: $1.37 diluted ($1.79 adjusted) vs. prior year $0.82 ($1.55 adjusted). Record full-year free cash flow of $68.1M and 17 consecutive record revenue quarters. | ||||||||||
| May 18 Mon | EXPI | eXp World Holdings, Inc. | Real Estate | 785M | — | $6.74 | +37.0% | — | — | 0 |
| No source documents retrieved | ||||||||||
| CAEP | Cantor Equity Partners III, Inc. Class A Ordinary Shares | Financial Services | 526M | — | $15.00 | +20.1% | — | — | 0 | |
| No source documents retrieved | ||||||||||
| May 14 Thu | ELMD | Electromed, Inc. | Healthcare | 223M | — | $34.03 | +25.1% | — | beat | 8 |
| Q3 FY2026 earnings beat: Net revenues $18.6M (+18.4% YoY) vs prior guidance; Net income $3.0M or $0.35 diluted EPS (+58.8% YoY) vs $0.21 prior year. Operating income surged 76.0% to $3.8M (20.3% margin). 14th consecutive quarter of YoY revenue and profit growth. Homecare revenue per sales rep annualized $1.18M exceeded company target range of $1.0M-$1.1M. Strong operational foundation with 86% covered lives under contract and manufacturing optimization complete. | ||||||||||
| STAA | STAAR Surgical Company | Healthcare | 1.4B | $29.40 | $36.37 | +23.7% | AMC | beat | 9 | |
| Q1 2026 net sales of $93.5M (up 119.6% Y/Y) versus prior year $42.6M; GAAP EPS of $0.10 vs prior year loss of $(1.10); Adjusted EBITDA of $24.4M ($0.48/share) vs prior year loss of $(26.3)M ($(0.53)/share); gross margin expanded to 73.6% from 65.8% Y/Y; return to profitability with record first-quarter sales and strong China recovery after 2025 inventory issues | ||||||||||
| May 13 Wed | VPG | Vishay Precision Group, Inc. | Technology | 829M | — | $85.57 | +28.5% | — | beat | 8 |
| VPG reported Q1 FY2026 revenue of $84.4M (17.6% YoY growth) with bookings of $102.1M (25.5% sequential growth, third-highest quarterly level in company history). Sensors segment bookings grew 29.0% sequentially with book-to-bill of 1.36. Consolidated book-to-bill of 1.21 with all three segments exceeding 1.0. Company added $1.0M in humanoid robotics orders with engineering discussions underway with a fourth humanoid developer. Gross margin improved to 39.0% vs 37.7% prior year. | ||||||||||
| VELO | Velo3D, Inc. | Technology | 256M | $14.06 | $17.47 | +24.2% | AMC | contract | 9 | |
| Velo3D awarded $9.8 million five-year IDIQ contract from Defense Logistics Agency (DLA) for Joint Additive Manufacturing Acceptability (JAMA) Pilot Parts Program. Combined with Q1 2026 revenue of $13.8 million (48% YoY growth vs $9.3M in Q1 2025), gross margin improvement to 17.2% from 7.5%, and reaffirmed full-year 2026 guidance of $60-70M revenue with positive EBITDA in H2 2026. Company also closed $50 million equity raise in April 2026 and reduced debt by 70% to $9M. | ||||||||||
| EOSE | Eos Energy Enterprises, Inc. | Industrials | 1.7B | $8.10 | $10.00 | +23.5% | BMO | partner | 9 | |
| Eos announced formation of Frontier Power USA with Cerberus Capital Management to develop long-duration energy storage projects. Cerberus committed $100 million equity; Eos targeting ~$150 million contribution. Partnership includes 2 GWh firm capacity reservation agreement. Additionally, Q1 2026 revenue hit $57.0 million (445% YoY increase vs $10.5M prior year); backlog expanded to $644.6 million representing 2.6 GWh; pipeline grew 56% YoY to $24.3 billion. Company reaffirmed full-year 2026 guid | ||||||||||
| WOLF | Wolfspeed, Inc. | Technology | 2.0B | — | $65.50 | +21.8% | — | — | 0 | |
| No source documents retrieved | ||||||||||
| May 12 Tue | CNCK | Coincheck Group N.V. | Financial Services | 245M | $1.75 | $2.31 | +32.0% | BMO | — | 0 |
| No source documents retrieved | ||||||||||
| QUBT | Quantum Computing, Inc. | Technology | 1.3B | $10.18 | $13.12 | +28.9% | AMC | contract | 9 | |
| Q1 2026 revenue surged to $3.7 million from $39 thousand in Q1 2025 (9,385% YoY increase), driven by acquisitions of Luminar Semiconductor ($110 million all-cash deal completed Feb 2026) and NuCrypt ($5 million completed Mar 2026). Contract backlog of $16 million established. Fab 1 facility ramping small-batch manufacturing with early revenue generation. Dirac-3 quantum optimization machine placed on Quantum Corridor's quantum-safe commercial network. | ||||||||||
| VPG | Vishay Precision Group, Inc. | Technology | 829M | $66.44 | $79.79 | +20.1% | BMO | beat | 8 | |
| Q1 FY2026 revenue $84.4M beat implied consensus (17.6% YoY growth vs prior year $71.7M). Bookings $102.1M exceeded $100M threshold, up 25.5% sequentially, highest in 3 quarters. Book-to-bill 1.21 across all segments. Sensors segment bookings +29% sequential; Measurement Systems +32.3% sequential. Adjusted EPS $0.07 matched prior year but GAAP EPS improved from -$0.07 loss to -$0.02 loss. Gross margin 39.0% vs 37.7% prior year. CEO highlighted strong demand in semiconductors, data centers, avioni | ||||||||||
| May 11 Mon | ODYS | Odysight.ai Inc. | Technology | 76M | — | $10.54 | +136.3% | — | partner | 7 |
| Odysight.ai signed a Commercial Collaboration Agreement with GACI Technologies (announced 2026-04-17) to expand AI-powered predictive maintenance into the French aerospace and defense market. This partnership marks the company's entry into France's aerospace, defense, and government aviation sectors through a local partner, representing geographic expansion of its visual sensing and predictive maintenance solutions. | ||||||||||
| MRAM | Everspin Technologies, Inc. | Technology | 504M | — | $35.89 | +33.0% | — | contract | 9 | |
| Everspin Technologies announced a $40 million agreement with a U.S. prime contractor to provide Toggle MRAM process technology capabilities and engineering services for United States Defense Industrial Base customers. This contract win was announced on 2026-04-30, alongside Q1 2026 earnings results that beat analyst expectations (Q1 guidance was $0.070-0.120 EPS; analysts expected $0.09 EPS and $14.60M revenue). | ||||||||||
| BZH | Beazer Homes USA, Inc. | Consumer Cyclical | 510M | — | $24.42 | +30.1% | — | contract | 10 | |
| Dream Finders Homes submitted a bid to acquire Beazer Homes USA for approximately $704 million ($25.75 per share). Millrose Properties announced it will provide land banking capital support for the acquisition and intends to acquire homesites currently owned by Beazer Homes upon transaction completion, enabling capital-efficient growth while preserving balance sheet flexibility. | ||||||||||
| ACH | Accendra Health, Inc. | Healthcare | 285M | — | $4.64 | +28.9% | BMO | restrct | 8 | |
| Accendra Health announced a comprehensive balance sheet optimization transaction exceeding $1.5 billion with commitments from existing creditors on May 11, 2026 (BMO earnings release). The deal significantly extends maturities and reduces total leverage. This follows Q1 2026 earnings results and addresses the company's high net leverage (expected 4.9-5x by end-2026). The restructuring strengthens the balance sheet materially, removing a major overhang that previously pressured the stock. | ||||||||||
| VCX | Fundrise Growth Tech Fund, LLC | Financial Services | 6.3B | — | $235.00 | +23.0% | — | partner | 6 | |
| xStocks and Fundrise announced partnership on 2026-03-27 to tokenize the Fundrise Innovation Fund (NYSE: VCX), bringing onchain access to a diversified portfolio of high-growth private technology companies including SpaceX, OpenAI, Anthropic, and Databricks through tokenized asset infrastructure powered by Payward. Additionally, VCX announced new investment in Erebor Bank on 2026-03-23, a newly chartered national bank founded by Palmer Luckey (Oculus/Anduril co-founder) designed to serve the tec | ||||||||||
| GSIT | GSI Technology, Inc. | Technology | 238M | — | $10.35 | +22.5% | — | contract | 7 | |
| GSI Technology announced it was awarded Phase One of a Smart City Project subsequent to Q4 2026 quarter end (reported May 7, 2026). Additionally, on April 28, 2026, GSI received a Phase-II U.S. Army xTech SBIR contract worth just under $2.0 million for developing a Ruggedized Edge AI Platform for Tactical Defense Applications using its Gemini-II processor. | ||||||||||
| MNDY | monday.com Ltd. | Technology | 3.9B | $72.07 | $87.32 | +21.2% | BMO | beat | 9 | |
| Q1 2026 non-GAAP EPS of $1.15 beat Zacks Consensus of $0.96 (20% upside). Revenue of $351.3M grew 24% YoY, beating expectations. Non-GAAP operating margin maintained at 14% despite 190bps FX headwind. GAAP EPS $0.57 vs $0.52 YoY. Record GAAP operating income $19.8M (6% margin) vs $9.8M prior year. Strong net dollar retention 110%, with customers >$500K ARR up 74% YoY to 99 customers (6% of ARR). | ||||||||||
8–10 = trade signal
5–7 = research more
0–4 = stay out / no clear catalyst
Orange sector = Healthcare (binary event risk)
· Hover sector for industry · Hover ticker for price chart